Diagnostic Microbiology & Infectious Disease
Volume 67, Issue 1 , Pages 56-60 , May 2010

Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods

  • Michael A. Pfaller

      Affiliations

    • Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
    • Corresponding Author InformationCorresponding author. Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA. Tel.: +1-319-356-8615; fax: +1-319-356-4916.
    • ,
  • Linda Boyken

      Affiliations

    • Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
    • ,
  • Richard J. Hollis

      Affiliations

    • Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
    • ,
  • Jennifer Kroeger

      Affiliations

    • Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
    • ,
  • Shawn A. Messer

      Affiliations

    • Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
    • ,
  • Shailesh Tendolkar

      Affiliations

    • Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
    • ,
  • Daniel J. Diekema

      Affiliations

    • Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA
    • Department of Medicine, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA

Received 24 April 2009 ,Accepted 8 January 2010.

References 

  1. Arendrup MC, Perkhofer S, Howard SJ, Garcia-Effron G, Vishukumar A, Perlin D, et al. Establishing in vitro–in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins. Antimicrob. Agents Chemother. 2008;52:3504–3511
  2. Betts R, Glasmacher A, Maertens J, Maschmeyer G, Vazquez JA, Teppler H, et al. Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients. Cancer. 2006;106:466–473
  3. Clinical and Laboratory Standards Institute . Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard - second edition, M38-A2. Wayne, PA: CLSI; 2008;
  4. Gardiner RE, Souterpoulas P, Park S, Perlin DS. Characterization of Aspergillus fumigatus mutants with reduced susceptibility to caspofungin. Med. Mycol. 2005;43(Suppl. 1):S299–S305
  5. Kahlmeter G, Brown DFJ, Goldstein FW, MacGowen AP, Mouten JW, Osterlund A, et al. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J. Antimicrob. Chemother. 2003;52:145–148
  6. Kahn JN, Hsu MJ, Racine F, Giacobbe R, Motyl M. Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: inhibition of glucan synthase and reduction β-d-1,3 glucan levels in culture. Antimicrob. Agents Chemother. 2006;50:2214–2216
  7. Madureira A, Bergeron A, Lacroix C, Robin M, Rocha V, Peffault de Latour R, et al. Breakthrough invasive aspergillosis in allogenic haematopoietic stem cell transplant recipients treated with caspofungin. Int. J. Antimicrob. Agents. 2007;30:551–554
  8. Maertens J, Raad I, Petrikkos G, Boogaerts M, Selleslag D, Petersen FB, et al. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin. Infect. Dis. 2004;39:1563–1571
  9. Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, et al. Epidemiology and outcome of invasive fungal infections in adult hematopoietic stem cell transplant recipients: analysis of multicenter Prospective Antifungal Therapy (PATH) Alliance Registry. Clin. Infect. Dis. 2009;48:265–273
  10. Odds FC, Motyl M, Andrade R, Bille J, Canton E, Cuena-Estrella M, et al. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species. J. Clin. Microbiol. 2004;42:3475–3482
  11. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2009;48:503–535
  12. Perlin DS. Resistance to echinocandin-class antifungal drugs. Drug Resist. Updat. 2007;10:121–130
  13. Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, et al. In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species. J. Clin. Microbiol. 2008;46:2568–2572
  14. Rocha EMF, Garcia-Effron G, Park S, Perlin DS. A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus. Antimicrob. Agents Chemother. 2007;51:4174–4176
  15. Rodriquez-Tudela JL, Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Monzon A, Cuenca-Estrella M. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob. Agents Chemother. 2008;52:2468–2472
  16. Romano J, Nimrod G, Ben-Tal N, Shadkchan Y, Baruch K, Sharon H, et al. Description of the Aspergillus fumigatus ECM33 homologue results in rapid conidial germination, antifungal resistance and hypervirulence. Microbiology. 2006;152:1919–1928
  17. Snelders E, van der Lee HAL, Kuijpers J, Rijs AJMM, Varga J, Samson RA, et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLOS Med. 2008;5:1629–1637
  18. Turnidge J, Paterson DL. Setting and revising antibacterial susceptibility breakpoints. Clin. Microbiol. Rev. 2007;20:391–408
  19. Turnidge J, Kahlmeter G, Kronvall G. Statistical characterization of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values. Clin. Microbiol. Infect. 2006;12:418–425
  20. van der Linder JWM, Jansen RR, Bresters D, Visser CE, Geerlings SE, Kuijper EJ, et al. Azole-resistant central nervous system aspergillosis. Clin. Infect. Dis. 2009;48:1111–1113
  21. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin. Infect. Dis. 2008;46:327–380

PII: S0732-8893(10)00005-2

doi: 10.1016/j.diagmicrobio.2010.01.001

Diagnostic Microbiology & Infectious Disease
Volume 67, Issue 1 , Pages 56-60 , May 2010

Article Tools

* Image Usage & Resolution